The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Abstract
Insulin-like growth factors (IGFs) are important mediators of growth, development, and survival, are synthesized by almost any tissue in the body, and their action is modulated by a complex network of molecules, including binding proteins, proteases and receptors, which all comprise the IGF system. Evidence from in vitro and animal studies suggests that overexpression of IGFs by cancer cells and/or the nearby stroma as well as the type IGF-I receptor by the cancer cells may play a significant role in establishing a transformed phenotype in an increasing number of malignancies. More specifically, IGFs may promote cell cycle progression and inhibition of apoptosis either by directly associating with other growth factors or indirectly by interacting with other molecular systems which have an established role in carcinogenesis and cancer promotion, such as the steroid hormones and integrins. In addition, a growing number of epidemiologic studies suggest that increased serum levels of IGFs and/or altered levels of their binding proteins are associated with increased risk for developing several malignancies. These data indicate that IGF dysregulation should now be considered as an important independent factor for cancer risk, and a potential target for novel antineoplastic therapies and/or preventative strategies in high-risk groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Liu, J.-P., Baker, J., Perkins, A. S., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80084-4 · Cited by 2,855
Role of insulin-like growth factors in embryonic and postnatal growth
Baker, J., Liu, J.-P., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80085-6 · Cited by 2,463
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Nutritional Regulation of the Insulin-Like Growth Factors*
THISSEN, J.-P., KETELSLEGERS, J.-M., & UNDERWOOD, L. E. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-1-80 · Cited by 1,579
Nutritional regulation of the insulin-like growth factors
Thissen, J. P. (1994) · Endocrine Reviews · doi:10.1210/er.15.1.80 · Cited by 1,578
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor
LEROITH, D., WERNER, H., BEITNER-JOHNSON, D., & ROBERTS, A. T. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-143 · Cited by 1,423
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J.-L., Stannard, B., Butler, A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,420
Tamoxifen in the Treatment of Breast Cancer
Osborne, C. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392207 · Cited by 1,320
D'Ercole, A. J., Stiles, A. D., & Underwood, L. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.935 · Cited by 1,186
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Rajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
Cell Proliferation in Carcinogenesis
Cohen, S. M., & Ellwein, L. B. (1990) · Science · doi:10.1126/science.2204108 · Cited by 1,050
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938
Sjögren, K., Liu, J.-L., Blad, K., Skrtic, S., Vidal, O., Wallenius, V., LeRoith, D., Törnell, J., Isaksson, O. G. P., Jansson, J.-O., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7088 · Cited by 938
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5007 · Cited by 805
IGF-I is required for normal embryonic growth in mice.
Powell-Braxton, L., Hollingshead, P., Warburton, C., Dowd, M., Pitts-Meek, S., Dalton, D., Gillett, N., & Stewart, T. A. (1993) · Genes & Development · doi:10.1101/gad.7.12b.2609 · Cited by 795
Stewart, C. E., & Rotwein, P. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.4.1005 · Cited by 776
Rajah, R., Valentinis, B., & Cohen, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12181 · Cited by 722
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Self-citationPlasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554
Dennis, P. A., & Rifkin, D. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.580 · Cited by 516
Regulation of embryonic growth and lysosomal targeting by the imprintedIgf2/Mpr gene
Wang, Z.-Q., Fung, M. R., Barlow, D. P., & Wagner, E. F. (1994) · Nature · doi:10.1038/372464a0 · Cited by 472
Oh, Y., Müller, H. L., Lamson, G., & Rosenfeld, R. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82426-7 · Cited by 472
SCHWANDER, J. C., HAURI, C., ZAPF, J., & FROESCH, E. R. (1983) · Endocrinology · doi:10.1210/endo-113-1-297 · Cited by 445
Dunn, S. E., Kari, F. W., French, J. E., Leininger, J. R., Travlos, G. S., Wilson, R., & Barrett, J. C. (1997) · PubMed · Cited by 438
Yee, D., Paik, S., Lebovic, G. S., Marcus, R. R., Favoni, R. E., Cullen, K. J., Lippman, M. E., & Rosen, N. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-3-509 · Cited by 399
Umayahara, Y., Kawamori, R., Watada, H., Imano, E., Iwama, N., Morishima, T., Yamasaki, Y., Kajimoto, Y., & Kamada, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34025-5 · Cited by 389
Stewart, A. J., Johnson, M. D., May, F. E., & Westley, B. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45342-7 · Cited by 381
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
Mantzoros, C., Tzonou, A., Signorello, L., Stampfer, M., Trichopoulos, D., & Adami, H.-O. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.520 · Cited by 366
Self-citationTannenbaum, G. S., Guyda, H. J., & Posner, B. I. (1983) · Science · doi:10.1126/science.6338593 · Cited by 360
Valentinis, B. (1995) · Molecular Endocrinology · doi:10.1210/me.9.3.361 · Cited by 327
Hormonal Predictors of Prostate Cancer: A Meta-Analysis
Shaneyfelt, T., Husein, R., Bubley, G., & Mantzoros, C. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.847 · Cited by 310
Self-citationSecretion of an insulin-like growth factor-I-related protein by human breast cancer cells.
Huff, K. K., Kaufman, D., Gabbay, K. H., Spencer, E., Lippman, M. E., & Dickson, R. B. (1986) · PubMed · Cited by 305
Molecules in focus Insulin-like growth factor II (IGF-II)
O'Dell, S. D., & Day, I. N. M. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00048-x · Cited by 304
The IGF-I Receptor in Cancer Research
Baserga, R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4667 · Cited by 292
van Golen, K. L., Davies, S. J., Wu, Z.-F., Wang, Y., Bucana, C. D., Root, H., Chandrasekharappa, S. C., Strawderman, M. S., Ethier, S. P., & Merajver, S. D. (1999) · PubMed · Cited by 287
DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3455 · Cited by 281
Leal, S. M., Liu, Q., Huang, S. S., & Huang, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20572 · Cited by 255
Pandini, G., Vigneri, R., Costantino, A., Frasca, F., Ippolito, A. M., Fujita‐Yamaguchi, Y., Siddle, K., Goldfine, I. D., & Belfiore, A. (1999) · PubMed · Cited by 255
Expression of insulin-like growth factor-1 receptor in human colorectal cancer
Hakam, A., Yeatman, T. J., Lu, L., Mora, L., Marcet, G., Nicosia, S. V., Karl, R. C., & Coppola, D. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90027-8 · Cited by 239
Kanety, H. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.1.229 · Cited by 236
Pietrzkowski, Z. J., Mulholland, G., Gomella, L. G., Jameson, B. A., Wernicke, D., & Baserga, R. (1993) · PubMed · Cited by 236
BAXTER, R. C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-2-265 · Cited by 233
Huynh, H., Yang, X., & Pollak, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1016 · Cited by 219
Insulin-Like Growth Factor-I in Relation to Premenopausal Ductal Carcinoma in Situ of the Breast
Bohlke, K., Cramer, D. W., Trichopoulos, D., & Mantzoros, C. S. (1998) · Epidemiology · doi:10.1097/00001648-199809000-00018 · Cited by 215
Self-citationButt, A. J., Firth, S. M., King, M. A., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908888199 · Cited by 214
Iwamura, M., Sluss, P. M., Casamento, J. B., & Cockett, A. T. K. (1993) · The Prostate · doi:10.1002/pros.2990220307 · Cited by 213
Bruning, P. F., Van Doorn, J., Bonfrèr, J. M. G., Van Noord, P. A. M., Korse, C. M., Linders, T. C., & Hart, A. A. M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620306 · Cited by 210
Physiological role of the insulin-like growth factor binding proteins
Zapf, J. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320645 · Cited by 192
Childhood energy intake and adult mortality from cancer: the boyd orr cohort study
Frankel, S., Gunnell, D. J., Peters, T. J., Maynard, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7130.499 · Cited by 186
Akagi, Y., Liu, W., Zebrowski, B. K., Xie, K., & Ellis, L. M. (1998) · PubMed · Cited by 184
Holly, J. M. P., & Wass, J. A. H. (1989) · Journal of Endocrinology · doi:10.1677/joe.0.1220611 · Cited by 181
Characterization of insulinlike growth factor I receptors in human colon cancer
Guo, Y., Narayan, S., Yallampalli, C., & Singh, P. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)70001-r · Cited by 177
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study
Orme, S. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2730 · Cited by 173
Tennant, M. K. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3774 · Cited by 171
Cellular Actions of Insulin-Like Growth Factor Binding Proteins
Ferry, R., Katz, L., Grimberg, A., Cohen, P., & Weinzimer, S. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978719 · Cited by 166
Miller, W. H. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981015)83:8<1471::aid-cncr1>3.0.co;2-6 · Cited by 163
Arai, T., Busby, W. H., & Clemmons, D. R. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895319 · Cited by 162
Chott, A., Sun, Z., Morganstern, D., Pan, J., Li, T., Susani, M., Mosberger, I., Upton, M. P., Bubley, G. J., & Balk, S. P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65229-7 · Cited by 161
Dupont, J., Karas, M., & LeRoith, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006741200 · Cited by 155
Remacle-Bonnet, M. M., Garrouste, F. L., Heller, S., André, F., Marvaldi, J. L., & Pommier, G. J. (2000) · PubMed · Cited by 141
Ho, P. J., & Baxter, R. C. (1997) · PubMed · Cited by 137
Presence of somatomedin receptors on primary human breast and colon carcinomas
Pollak, M., Perdue, J. F., Margolese, R. G., Baer, K. A., & Richard, M. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90218-7 · Cited by 136
Werner, H., & Roith, D. L. (1997) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v8.i1.40 · Cited by 134
Burger, A. M., Zhang, X., Li, H., Ostrowski, J. L., Beatty, B., Venanzoni, M. C., Papas, T. S., & Seth, A. K. (1998) · Oncogene · doi:10.1038/sj.onc.1201772 · Cited by 133
Convergent signalling in the action of integrins, neuropeptides, growth factors and oncogenes.
Rozengurt, E. (1995) · PubMed · Cited by 132
Rosen, C. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1384 · Cited by 130
Kim, S. O., Park, J. G., & Lee, Y. I. (1996) · PubMed · Cited by 128
Transgenic mouse models for studying the functions of insulin‐like growth factor‐binding proteins
Schneider, M. R., Lahm, H., Wu, M., Hoeflich, A., & Wolf, E. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.629 · Cited by 128
Kaklamani, V., Linos, A., Kaklamani, E., Markaki, I., Koumantaki, Y., & Mantzoros, C. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3291 · Cited by 127
Self-citationHormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men
Allen, N. E., Appleby, P. N., Davey, G. K., & Key, T. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1152 · Cited by 126
Insulinlike growth factors and binding proteins in colon cancer
Singh, P., & Rubin, N. H. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90971-e · Cited by 124
Tennant, M. K., Thrasher, J. B., Twomey, P. A., Birnbaum, R. S., & Plymate, S. R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550786 · Cited by 121
Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid
Kang, J. X., Li, Y., & Leaf, A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13671 · Cited by 120
Pratt, S. E., & Pollak, M. (1993) · PubMed · Cited by 118
Petley, T., Graff, K., Jiang, W., Yang, H., & Florini, J. R. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978701 · Cited by 117
Insulin-like growth factor binding protein (IGFBP) proteases: Functional regulators of cell growth
Rajah, R., Katz, L. E. L., Nunn, S. E., et al. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00012-7 · Cited by 117
Renehan, A. G., Jones, J., Potten, C. S., Shalet, S. M., & O’Dwyer, S. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1462 · Cited by 116
Flyvbjerg, A., Mogensen, O. E., Mogensen, B., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4085 · Cited by 114
Frystyk, J., Ivarsen, P., Skjærbæk, C. B., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00798.x · Cited by 108
Insulin-like growth factor binding proteins: gene structure and expression.
Mm, R., & Al, B. (1992) · PubMed · Cited by 108
Kaklamani, V., Linos, A., Kaklamani, E., Markaki, I., & Mantzoros, C. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.813 · Cited by 106
Self-citationExpression of IGF-I and IGF-II mRNA in breast tissue
Paik, S. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01833331 · Cited by 103
Sprenger, C. C. T., Damon, S. E., Hwa, V., Rosenfeld, R. G., & Plymate, S. R. (1999) · PubMed · Cited by 102
Mira, E., Mañes, S., Lacalle, R. A., Márquez, G., & Martínez‐A, C. (1999) · Endocrinology · doi:10.1210/endo.140.4.6623 · Cited by 100
Karasik, A., Menczer, J., Pariente, C., et al. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.7508947 · Cited by 95
High-risk colorectal adenomas and serum insulin-like growth factors
Renehan, A. G., Painter, J. E., Atkin, W. S., Potten, C. S., Shalet, S. M., & O’Dwyer, S. (2001) · British journal of surgery · doi:10.1046/j.1365-2168.2001.01645.x · Cited by 91
Guvakova, M. A., & Surmacz, E. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4566 · Cited by 88
Culouscou, J., & SHOYAB, M. (1991) · PubMed · Cited by 87
Maile, L. A., & Holly, J. M. P. (1999) · Growth Hormone & IGF Research · doi:10.1054/ghir.1999.0096 · Cited by 85
Lee, Y. I., Lee, S., Lee, Y. I., Bong, Y., Hyun, S. W., Yoo, Y. D., Kim, S., Kim, Y. W., & Poo, H. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201760 · Cited by 80
Ayabe, T., Tsutsumi, O., Sakai, H., Yoshikawa, H., Yano, T., Kurimoto, F., & Taketani, Y. (1997) · Endocrine Journal · doi:10.1507/endocrj.44.419 · Cited by 78
Gregory, C. W., Kim, D., Ye, P., D’Ercole, A. J., Pretlow, T. G., Mohler, J. L., & French, F. S. (1999) · Endocrinology · doi:10.1210/endo.140.5.6702 · Cited by 75
Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men
Stuver, S. O., Kuper, H., Τζώνου, Α., Λάγιου, Π., Spanos, E., Hsieh, C.-C., Mantzoros, C. S., & Trichopoulos, D. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000701)87:1<118::aid-ijc17>3.0.co;2-w · Cited by 73
Self-citationNolan, C. M., Kyle, J. W., Watanabe, H., & Sly, W. S. (1990) · Cell Regulation · doi:10.1091/mbc.1.2.197 · Cited by 71
Butler, A. A., Blakesley, V. A., Poulaki, V., Tsokos, M., Wood, T. L., LeRoith, D., & Pouliki, V. (1998) · PubMed · Cited by 67
Li, S., Goko, H., Xu, Z., et al. (1998) · Cell and Tissue Research · doi:10.1007/s004410051016 · Cited by 66
Conover, C. A., Clarkson, J. T., & Bale, L. K. (1996) · Endocrinology · doi:10.1210/en.137.6.2286 · Cited by 64
Seely, B. L., Reichart, D. R., Staubs, P. A., Jhun, B. H., Hsu, D. S., Maegawa, H., Milarski, K. L., Saltiel, A. R., & Olefsky, J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.19151 · Cited by 64
Plymate, S. R., Bae-Jump, V. L., Maddison, L. A., Quinn, L. S., & Ware, J. L. (1997) · Endocrinology · doi:10.1210/endo.138.4.5071 · Cited by 62
Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia
Petridou, E. T., Dessypris, N., Spanos, E., Mantzoros, C. S., Skalkidou, A., Kalmanti, M., Koliouskas, D. E., Kosmidis, H. V., Panagiotou, J. P., Piperopoulou, F., et al. (1999) · International Journal of Cancer · Cited by 61
Self-citationTennant, M. K., Thrasher, J. B., Twomey, P. A., Birnbaum, R. S., & Plymate, S. R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855838 · Cited by 61
Kleinman, D., Karas, M., Danilenko, M., Arbell, A., Roberts, C. T., LeRoith, D., Levy, J., & Sharoni, Y. (1996) · Endocrinology · doi:10.1210/endo.137.3.8603578 · Cited by 60
Michell, N. P., LANGMAN, M. J. S., & Eggo, M. C. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.337 · Cited by 59
Rutanen, E. ‐., Stenman, S., Blum, W. F. P., Kärkkäinen, T., Lehtovirta, P., & Stenman, U. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.1.199 · Cited by 58
Insulin-like Growth Factor-1 (IGF-1) Receptor-Insulin Receptor Substrate Complexes in the Uterus
Richards, R. G., Walker, M. P., Sebastian, J., & DiAugustine, R. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11962 · Cited by 52
Insulin‐like Growth Factor‐I (IGF‐I) Receptors in Breast Cancer
PEZZINO, V., Papa, V., Milazzo, G., Gliozzo, B., Russo, P., & Scalia, P. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb16236.x · Cited by 47
Bontenbal, M., Foekens, J. A., Lamberts, S., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.18 · Cited by 45
Huynh, H. T., Seyam, R. M., & Brock, G. B. (1998) · PubMed · Cited by 45
Papa, V., Costantino, A., & Belfiore, A. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00114-8 · Cited by 31
Lee, D. Y., Yang, D. H., Kang, C. W., et al. (1997) · Journal of Korean Medical Science · doi:10.3346/jkms.1997.12.1.32 · Cited by 27
Remacle-Bonnet, M. M., Garrouste, F. L., Atiq, F. E., Marvaldi, J. L., & Pommier, G. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118020 · Cited by 25
Evans, J. D., Eggo, M. C., Donovan, I. A., et al. (1997) · International Journal of Pancreatology · doi:10.1007/bf02787466 · Cited by 17
Boisclair, Y. R., Hurst, K. R., Ueki, I., Tremblay, M. L., & Ooi, G. T. (2000) · Pediatric Nephrology · doi:10.1007/s004670000333 · Cited by 15
Mauras, N., Quarmby, V. E., & Bloedow, D. C. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.4.e579 · Cited by 7
Cited by
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
Self-citationAngiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., et al. (2022) · Cancers · doi:10.3390/cancers14071732 · Cited by 920
“More significant insulin signaling leads to increased metabolic activity within the cell, which leads to more oxidative stress and DNA damage [46,47].”
Background
Metadata
- Authors
- Moschos, S. J., & Mantzoros, C. S.
- Venue
- Oncology
- Publisher
- S. Karger AG
- Published
- 2002
- Volume
- 63
- Issue
- 4
- Pages
- 317-332
- ISSN
- 0030-2414 (ISSN-L)
- 1423-0232
- OpenAlex
- W2007278291
- Cited by
- 371
- References
- 119
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.